Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-16-004186
Filing Date
2016-03-16
Accepted
2016-03-16 15:28:40
Documents
68
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tlog-20151231x10k.htm 10-K 2680743
2 EX-21 tlog-20151231ex21eb1443b.htm EX-21 12274
3 EX-23.1 tlog-20151231ex2314bb24e.htm EX-23.1 2654
4 EX-31.1 tlog-20151231ex311b5bbbb.htm EX-31.1 17246
5 EX-31.2 tlog-20151231ex3121bf66d.htm EX-31.2 17764
6 EX-32.1 tlog-20151231ex3215d101d.htm EX-32.1 6856
7 EX-32.2 tlog-20151231ex32253853e.htm EX-32.2 6718
  Complete submission text file 0001558370-16-004186.txt   10082546

Data Files

Seq Description Document Type Size
8 EX-101.INS tlog-20151231.xml EX-101.INS 2219966
9 EX-101.SCH tlog-20151231.xsd EX-101.SCH 58472
10 EX-101.CAL tlog-20151231_cal.xml EX-101.CAL 66324
11 EX-101.DEF tlog-20151231_def.xml EX-101.DEF 288983
12 EX-101.LAB tlog-20151231_lab.xml EX-101.LAB 671341
13 EX-101.PRE tlog-20151231_pre.xml EX-101.PRE 457928
Mailing Address 343 PHOENIXVILLE PIKE MALVERN PA 19355
Business Address 343 PHOENIXVILLE PIKE MALVERN PA 19355 610-889-9900
TETRALOGIC PHARMACEUTICALS CORP (Filer) CIK: 0001361248 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36208 | Film No.: 161509556
SIC: 2834 Pharmaceutical Preparations